diclofenac has been researched along with Hyperamylasemia in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Hyperamylasemia: A condition with abnormally elevated level of AMYLASES in the serum. Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute pancreatitis was observed in 13." | 1.42 | Assessment of Pharmacological Prophylaxis for Acute Pancreatitis Following ERCP in Patients with Choledoholithiasis. ( Kołomecki, K; Łubowska-Pająk, E, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Łubowska-Pająk, E | 1 |
| Kołomecki, K | 1 |
1 other study available for diclofenac and Hyperamylasemia
| Article | Year |
|---|---|
Assessment of Pharmacological Prophylaxis for Acute Pancreatitis Following ERCP in Patients with Choledoholithiasis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bile Duct Diseases; Cholangiopancreatography, | 2015 |